(Total Views: 583)
Posted On: 03/27/2020 4:25:36 PM
Post# of 153887
What wonderful press releases today!
First and foremost it's about getting any help possible to those who are suffering on the verge of death with COVID-19. So I contacted a couple of influential broadcast newspeople I know in NYC. I've briefly explained what CytoDyn has been doing and emailed links to today's two PRs. I'm praying what the PRs indicate and what Leronlimab seems to have the potential to do pans out and helps so many in the U.S. and around the globe.
On another note, not sure how a company ( CytoDyn ) can get in on the following upcoming event (would be great to be a speaker):
https://pages.questexnetwork.com/CoronavirusS...h2020.html
Scroll down the above link to the following where they've highlighted speakers on developing a vaccine (maybe these speakeres should be made aware of what CytoDyn has in Leronlimab):
The race to develop a vaccine for COVID-19
March 30, 2020 | Time: 3:00PM-4:00PM ET
In under three months, the novel coronavirus has spread to more than 100 countries, causing nearly 200,000 illnesses and thousands of deaths. The pandemic has created an urgent need for vaccines, and the scientific community is responding. Pharma companies, biotechs, governments, academic institutions, nonprofits and others are pooling resources to aid vaccine development, with one candidate already in early human tests. In this virtual roundtable, experts will discuss vaccine approaches in the works, plus challenges to development, potential timing of a deployable vaccine and more.
SPEAKERS
Shlomi Madar, Ph.D
VP Healthcare Solutions
Signals Analytics
Michael Breen
Associate Director of Infectious Diseases
GlobalData
Kizzmekia S. Corbett PhD
Research Fellow
NIH, NIAID, Vaccine Research Center
Jim Mayne, Ph.D.
Vice President, Science and Regulatory Advocacy
PhRMA
Eric von Hofe
Chief Scientific Officer
NuGenerex Immuno-Oncology (NGIO)
Eric Sagonowsky
https://www.fiercepharma.com/products/event
Be well and safe and stay healthy ... and very best to all with CYDY !
First and foremost it's about getting any help possible to those who are suffering on the verge of death with COVID-19. So I contacted a couple of influential broadcast newspeople I know in NYC. I've briefly explained what CytoDyn has been doing and emailed links to today's two PRs. I'm praying what the PRs indicate and what Leronlimab seems to have the potential to do pans out and helps so many in the U.S. and around the globe.
On another note, not sure how a company ( CytoDyn ) can get in on the following upcoming event (would be great to be a speaker):
https://pages.questexnetwork.com/CoronavirusS...h2020.html
Scroll down the above link to the following where they've highlighted speakers on developing a vaccine (maybe these speakeres should be made aware of what CytoDyn has in Leronlimab):
The race to develop a vaccine for COVID-19
March 30, 2020 | Time: 3:00PM-4:00PM ET
In under three months, the novel coronavirus has spread to more than 100 countries, causing nearly 200,000 illnesses and thousands of deaths. The pandemic has created an urgent need for vaccines, and the scientific community is responding. Pharma companies, biotechs, governments, academic institutions, nonprofits and others are pooling resources to aid vaccine development, with one candidate already in early human tests. In this virtual roundtable, experts will discuss vaccine approaches in the works, plus challenges to development, potential timing of a deployable vaccine and more.
SPEAKERS
Shlomi Madar, Ph.D
VP Healthcare Solutions
Signals Analytics
Michael Breen
Associate Director of Infectious Diseases
GlobalData
Kizzmekia S. Corbett PhD
Research Fellow
NIH, NIAID, Vaccine Research Center
Jim Mayne, Ph.D.
Vice President, Science and Regulatory Advocacy
PhRMA
Eric von Hofe
Chief Scientific Officer
NuGenerex Immuno-Oncology (NGIO)
Eric Sagonowsky
https://www.fiercepharma.com/products/event
Be well and safe and stay healthy ... and very best to all with CYDY !
(4)
(0)
